•  All abstracts must be submitted in English.

• Per author (- group) it is allowed to submit maximum 2 abstracts for oral presentations

• A clear description of the design should be included

• Do not only focus on statistical results, but also on its clinical relevance (expressed as eg. number needed to treat or minimal clinically important difference) and implications.

• Abstracts cannot exceed a limit of 2000 characters including spaces (excluding title, authors and affiliations).

• All abstracts undergo peer review process. Do not use names of authors, institutions or country in your abstract, otherwise it has to be rejected.

• Do not use product names or brands in your abstract, otherwise your abstract it has to be rejected.

• Your abstract should be structured as follows and each heading should be in a separate paragraph:

               Title

               Background

               Research question Design

               Methods

               Results Discussion

• Standard abbreviations do not need explanation. Otherwise abbreviations must be defined in brackets after when first used in the text.

• It is not recommended to submit result of one study dissipated into multiple abstracts

• The use of References is discouraged.

• An automatically generated confirmation will be sent to the email address of the contact person after an abstract submission.

• Please submit your abstract(s) in English, Ms. Word, Times New Roman font 12.

• Please submit your abstract(s) at the latest 27 June 2026.

• Authors will be notified of the acceptance of their abstract by email in early July 2026.

• After acceptance of your abstract the presenting author should register within two weeks. Otherwise the paper wil be rejected.